HENRY SCHEIN INC shareholders Q3 2023

HENRY SCHEIN INC's ticker is HSIC and the CUSIP is 806407102. A total of 543 filers reported holding HENRY SCHEIN INC in Q3 2023. The put-call ratio across all filers is 2.71 and the average weighting 0.1%.

HENRY SCHEIN INC shareholders Q3 2023
NameSharesValueWeighting ↓
BLAIR WILLIAM & CO/IL 9,766$725,1260.00%
Livforsakringsbolaget Skandia, Omsesidigt 390$28,9580.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 1,100$820.00%
Walleye Capital LLC 8,200$608,8500.00%
BANK OF NOVA SCOTIA 12,151$902,2110.00%
Salomon & Ludwin, LLC 205$15,2210.00%
New Millennium Group LLC 29$2,1530.00%
Versant Capital Management, Inc 98$7,2770.00%
PRICE T ROWE ASSOCIATES INC /MD/ 198,802$14,7620.00%
Impax Asset Management Group plc 12,840$953,3700.00%
COMMONWEALTH EQUITY SERVICES, LLC 10,115$7510.00%
AMERIPRISE FINANCIAL INC 91,242$6,774,7190.00%
Cambridge Investment Research Advisors, Inc. 4,899$3640.00%
Citadel Advisors 132,795$9,860,0290.00%
CWM, LLC 5,375$3990.00%
ROYAL BANK OF CANADA 87,263$6,479,0000.00%
UniSuper Management Pty Ltd 2,051$152,2870.00%
Steward Financial Group LLC 80$50.00%
Sunbelt Securities, Inc. 220$16,3350.00%
HighTower Advisors, LLC 13,370$992,0000.00%
About HENRY SCHEIN INC

Henry Schein Inc. is a leading provider of healthcare products and services to medical and dental practitioners around the world. The company was founded in 1932 and has since grown to become a Fortune 500 company with over 19,000 employees and operations in 31 countries.

Henry Schein's success can be attributed to its commitment to providing high-quality products and services to its customers. The company offers a wide range of products, including dental and medical supplies, equipment, and software solutions. In addition, Henry Schein provides practice management and consulting services to help healthcare professionals run their practices more efficiently.

One of the key factors that sets Henry Schein apart from its competitors is its focus on corporate social responsibility. The company has a strong commitment to sustainability and has been recognized for its efforts to reduce its environmental impact. In addition, Henry Schein has a long history of supporting charitable organizations and disaster relief efforts around the world.

Despite the challenges posed by the COVID-19 pandemic, Henry Schein has continued to perform well. In the second quarter of 2021, the company reported net sales of $2.1 billion, an increase of 45.8% compared to the same period in the previous year. This growth can be attributed to increased demand for healthcare products and services as a result of the pandemic.

Overall, Henry Schein's commitment to quality, sustainability, and social responsibility has helped it become a leader in the healthcare industry. With its strong financial performance and continued focus on innovation, the company is well-positioned for future success.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists HENRY SCHEIN INC's shareholders in Q3 2023. To view HENRY SCHEIN INC's shareholder history, click here.